Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06670820

iTBS in MCI and Mild AD

The Effects of Intermittent Theta-burst Stimulation on Cognitive Function in Patients With Mild Cognitive Impairment and Mild Alzheimer's Disease and the Role of Brain-Derived Neurotrophic Factor

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
National Defense Medical Center, Taiwan · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study aims to examine the effects of iTBS on cognitive function in individuals with MCI or mild AD, with a secondary objective of exploring prefrontal TBS mechanisms for cognitive function and the effect of iTBS on BDNF.

Conditions

Interventions

TypeNameDescription
DEVICEActive rTMSiTBS targeting the left dorsolateral prefrontal cortex (DLPFC) per session, total10 sessions
DEVICESham rTMSsham iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) per session, total 10 sessions

Timeline

Start date
2024-10-31
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2024-11-01
Last updated
2024-11-01

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06670820. Inclusion in this directory is not an endorsement.

iTBS in MCI and Mild AD (NCT06670820) · Clinical Trials Directory